Skip to main content

Year: 2026

Orange: Half-yearly report on Orange’s liquidity contract

Regulated informationParis, 6 July 2026 Half-yearly report on Orange’s liquidity contract As part of the liquidity contract signed by Orange with Rothschild Martin Maurel, the following assets appeared on the liquidity account as of June 30, 2026:150 000 shares € 43,267,912Over the period from 01/01/2026 to 06/30/2026, a total of was negotiated:  Number of transactions executed Volume exchanged Amount in €Buy side 11,814 11,860,816 205,104,091.14Sell side 12,736 11,710,816 202,742,669.09It is reminded that as of December 31, 2025 the following assets appeared on the liquidity account:0 share45,543,828 €Following the reorganization within the Rothschild & Co group and the transfer of market-making activities from Rothschild & Co Martin Maurel to Rothschild & Co Global Markets Solutions (Europe) SA,...

Continue reading

What is Excellence Behind the Wheel? Sysco’s 25 Inductees to the 2026 IFDA Truck Driver Hall of Fame

Sysco’s 2026 IFDA Hall of Fame InducteesJoin us in congratulating our 25 outstanding delivery partners inducted into the 2026 IFDA Hall of Fame. We thank them for their hard work, dedication and loyalty to our customers and communities.HOUSTON, July 06, 2026 (GLOBE NEWSWIRE) — Sysco Corporation (SYY) is proud to announce that 25 delivery partners have been named to the International Foodservice Distributors Association (IFDA) 2026 Truck Driver Hall of Fame, one of the highest honors in foodservice distribution. Sysco’s inductees are part of a record-breaking Hall of Fame class of 108 drivers recognized by IFDA this year. Nearly doubling Sysco’s representation from last year, the recognition reflects the strength of the company’s transportation teams and its ongoing commitment to safety and operational excellence....

Continue reading

Societe Generale: shares and voting rights as of 30 June 2026

NUMBER OF SHARES COMPOSING CURRENT SHARE CAPITAL AND TOTAL NUMBER OF VOTING RIGHTS AS OF 30 JUNE 2026 Regulated Information Paris, 6 July 2026 Information about the total number of voting rights and shares pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the AMF General Regulations.Date Number of shares composing current share capital Total number ofvoting rights30 June 2026744,394,214  Gross: 828,070,180Press contacts: Jean-Baptiste Froville_+33 1 58 98 68 00_ jean-baptiste.froville@socgen.comFanny Rouby_+33 1 57 29 11 12_ fanny.rouby@socgen.com Societe Generale Societe Generale is a top-tier European Bank with around 110,000 employees serving 27 million clients in 58 countries across the world. We have been supporting the development of our economies for over 160 years, providing our...

Continue reading

Monthly disclosure on share capital and voting rights on June 30, 2026

Regulated InformationIssy-les-Moulineaux, July 6, 2026 Sodexo: Monthly disclosure on share capital and voting rights Pursuant to Article L.233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers Registered name of the issuer: SODEXO 255, quai de la Bataille de Stalingrad – 92130 ISSY-LES-MOULINEAUXDate Total number of shares Actual voting rights * Theoretical voting rights **June 30, 2026147,454,887216,530,287218,127,618* Actual voting rights: all of the Company shares have the same voting rights, except for treasury shares which do not have voting rights and registered shares held for more than four years, which have double voting rights. ** Theoretical voting rights: the number of theoretical voting rights is calculated based on the shares having...

Continue reading

Zealand Pharma – Transactions related to share buy-back program (week 27, 2026)

Company announcement No. 31 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 27, 2026) Copenhagen, Denmark, July 6, 2026 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the “Program”) for week 27 (June 29 – July 3, 2026). The Program is carried out in accordance with Article 5 of Regulation (EU) No 596/2014 (the Market Abuse Regulation, “MAR”) and Commission Delegated Regulation (EU) 2016/1052 (the “Safe Harbour Regulation”). Reference is made to company announcement no. 15 / 2026 dated May 7, 2026, which sets out the full terms of the Program. Under the Program, Zealand Pharma may repurchase shares for a total...

Continue reading

Where Heritage Takes Form: The British Craftsmanship Behind FREELANDER 8’s Exterior Design

SHANGHAI, July 06, 2026 (GLOBE NEWSWIRE) — As a British Premium Intelligent All-Terrain brand carrying forward its heritage, Chery Group’s FREELANDER has officially detailed the full exterior design features of its first strategic nameplate: FREELANDER 8. Its exterior design strikes a refined balance between heritage recognition, understated premium aesthetics and purpose-driven functionality, with thoughtfully engineered details embedded throughout the bodywork to deliver a distinct and enduring visual presence. Front Fascia: Bold Identity and Precision CraftThe front end anchors the vehicle’s premium visual identity with signature design details. Inspired by European castle stone masonry, the Debossed Badging achieves sculptural three-dimensional depth via a breakthrough 4mm deep-groove process. The three-layer geometric...

Continue reading

authID Announces 2026 Annual Shareholder Meeting Results

DENVER, July 06, 2026 (GLOBE NEWSWIRE) — authID®  [Nasdaq: AUID], a leading provider of biometric identity verification and authentication solutions, today reported that its Annual Meeting of Shareholders was duly held via webcast today, July 6, 2026 at 10:00 am Eastern Time. At the meeting, all the directors nominated were duly elected, and all resolutions proposed were duly adopted. About authID Inc. authID (Nasdaq: AUID) ensures enterprises “Know Who’s Behind the Device™” for every customer or employee login and transaction through its easy-to-integrate, patented, biometric identity platform. authID quickly and accurately verifies a user’s identity, leveraging a 1-in-1-billion False Positive Rate for the highest level of assurance, coupled with industry-leading speed and privacy-preserving technology. Our...

Continue reading

Nasdaq Rings Opening Bell at the White House to Mark America 250 and the First Trading Day for Trump Accounts

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) — Nasdaq today rang the opening bell live from the White House, marking the celebration of 250 years of American independence — and the first trading day for Trump Accounts, a new initiative that expands access to long-term investing for American children. The White House ceremony brought together leaders from Nasdaq and the New York Stock Exchange (NYSE) alongside President Trump and senior government officials. It also marked the first joint opening bell ceremony between Nasdaq and the NYSE. “We are grateful to President Trump for his vision in creating Trump Accounts, and we are honored to help celebrate this historic milestone,” said Adena Friedman, Nasdaq Chair and CEO. “At Nasdaq, we believe in the power of long-term investing to change lives for the better. Now, every American...

Continue reading

Correction: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026

MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) — This press release corrects the earnings release date included in the earlier version issued on July 6, 2026. No other information has changed. Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2026 after the close of trading on Monday, August 3. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire’s Q2 2026 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast. If you plan to ask a question, please use the following...

Continue reading

Schouw & Co. share buy-back programme, week 27 2026

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount DKK    Accumulated until 26 June 2026 159,283 662.44 105,516,145    Monday, 29 June 2026 2,000 591.00 1,181,990    Tuesday, 30 June 2026 4,000 586.25 2,345,000    Wednesday, 1 July 2026 4,000 583.99 2,335,962    Thursday, 2 July 2026 4,000 605.89 2,423,544    Friday,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.